Pay vs Performance Disclosure - USD ($)

12 Months Ended

Jan. 12, 2025

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Dec. 31, 2022

Dec. 31, 2021

Pay vs Performance Disclosure

Pay vs Performance Disclosure, Table

Pay Versus Performance

The following tables provide pay versus performance information required by Regulation S-K. For information regarding the Company’s pay-for-performance philosophy and how the Company aligns executive compensation with the Company’s performance, refer to “Executive Compensation: Compensation Discussion and Analysis.”



Year	Summary Compensation Table (“SCT”) Total for First PEO(1)			SCT Total for Second PEO(1)			Compensation Actually Paid (“CAP”) to First PEO(2)			CAP to Second PEO			Average SCT Total for Non-PEO NEOs(3)			Average CAP to Non-PEO NEOs(2)(3)


2025		$	2,775,881		$	14,140,217		$	2,954,364		$	24,892,348		$	3,402,819		$	6,034,845

2024		$	3,301,012		N/A			$	4,424,038		N/A			$	2,078,530		$	2,611,401


2023		$	2,237,839		N/A			$	1,620,732		N/A			$	1,721,885		$	1,191,132


2022		N/A			$	4,655,746		N/A			$	540,703		$	1,699,411		$	364,560


2021		N/A			$	6,848,969		N/A			$	9,015,601		$	2,107,197		$	2,525,213



		Value of Initial Fixed $100 Investment Based On:


Year	Total Shareholder Return			Peer Group Total Shareholder Return(4)			Net Income (Loss) ($ in thousands)				Adjusted EBITDA ($ in thousands)(5)


2025		$	87.16		$	77.88		$	165,388			$	275,590

2024		$	53.46		$	78.31		$	(99,069	)		$	224,022


2023		$	37.90		$	75.74		$	(60,408	)		$	200,418


2022		$	60.55		$	77.81		$	66,331			$	241,033


2021		$	110.88		$	105.76		$	130,937			$	265,476

(1)

Dr. Swift served as our principal executive officer ("PEO") in 2025 until January 12, 2025, and Mr. Ordan served as our PEO for the remainder of 2025. Dr. Swift served as our PEO for the entirety of 2024 and 2023. Mr. Ordan served as our PEO for the entirety of 2021 and 2022. For purposes of the table, Dr. Swift is our First PEO and Mr. Ordan is our Second PEO.

(2)

Compensation “actually paid” is calculated in accordance with Item 402(v) of Regulation S-K, however, as required, the dollar amounts include (among other items) equity compensation that may be realizable in future periods, and as such, the dollar amounts shown do not fully represent the actual final amount of compensation earned or actually paid during the applicable years. The table below sets forth each adjustment made during the years presented in the table to calculate the compensation “actually paid,” in accordance with Item 402(v) of Regulation S-K, to our NEOs during each year in the table.

(3)

During 2025, our non-PEO NEOs consisted of Ms. Rossi, Ms. Moore and Mr. Neeb. In 2024, our non-PEO NEOs consisted of Ms. Rossi, Ms. Moore, Mr. Richards, Dr. Pickert and Mr. Wood. In 2023, our non-PEO NEOs consisted of Ms. Moore, Mr. Richards, Dr. Pickert and Mr. Wood. In 2022, our non-PEO NEOs consisted of Mr. Richards and Dominic Andreano, our former Executive Vice President and General Counsel, Ms. Moore and Dr. Swift. During 2021, our non-PEO NEOs consisted of Mr. Richards and Andreano, Mr. John C. Pepia, Ms. Moore and Roger “Mack” Hinson, M.D.

(4)

The peer group used by the Company consists of the companies used in the S&P 600 Health Care Index, the index used in the Company’s performance graph reported in Part II, Item 5 of its Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

(5)

Adjusted EBITDA is the financial measure from the Tabular List of 2025 Most Important Measures shown below, which, in the Company’s assessment, represents for 2025 the most important performance measure used to link compensation actually paid to our CEOs and other NEOs to the Company’s performance. Adjusted EBITDA is defined on page 34 and is a non-GAAP financial measure.


Adjustments to Calculate Compensation “Actually Paid” to First PEO(7)	2025				2024				2023


SCT Total		$	2,775,881			$	3,301,012			$	2,237,839


Minus: Grant Date Fair Value of Awards Granted During the Year(8)		$	(730,720	)		$	(1,180,087	)		$	(1,025,015	)


Plus (Minus): CAP Adjustments Calculated Using SEC Methodology(9)		$	909,203			$	2,303,113			$	407,908


CAP Total		$	2,954,364			$	4,424,038			$	1,620,732


Adjustments to Calculate Compensation “Actually Paid” to Second PEO(7)	2025				2022				2021

SCT Total		$	14,140,217			$	4,655,746			$	6,848,969


Minus: Grant Date Fair Value of Awards Granted During the Year(8)		$	(8,456,024	)		$	(3,500,013	)		$	(3,500,021	)


Plus (Minus): CAP Adjustments Calculated Using SEC Methodology(9)		$	19,208,155			$	(615,030	)		$	5,666,653


CAP Total		$	24,892,348			$	540,703			$	9,015,601


Adjustments to Calculate Compensation “Actually Paid” to	2025				2024				2023				2022				2021
Non-PEO NEOs(6)

SCT Total		$	3,402,819			$	2,078,530			$	1,721,885			$	1,699,411			$	2,107,197


Minus: Grant Date Fair Value of Awards Granted During the Year(7)		$	(1,853,151	)		$	(715,395	)		$	(931,681	)		$	(1,081,261	)		$	(990,016	)


Plus (Minus): CAP Adjustments Calculated Using SEC Methodology(8)		$	4,485,177			$	1,248,266			$	400,928			$	(253,590	)		$	1,408,032


CAP Total		$	6,034,845			$	2,611,401			$	1,191,132			$	364,560			$	2,525,213

(6)As shown in these tables, the Compensation “Actually Paid” totals represent the SCT totals for the applicable year, but adjusted as required by SEC rules to include the fair value of current and prior year equity awards that are outstanding, vested or forfeited during the applicable year, instead of the grant date value of awards granted during the applicable year.

(7)

Represents the total of the amounts reported in the Stock Awards and Option Awards columns of the SCT for the applicable year.

(8)

The fair value of equity component of the CAP calculation was determined in accordance with SEC methodology for this disclosure. Unlike the SCT, which reflects the grant date fair value of equity awards granted during the applicable year, the CAP table reflects equity fair value as follows:

•

for awards granted during the applicable year (and which are still outstanding), the year-end value; plus

•

for awards granted during prior years that were still outstanding as of the applicable year-end, the change in value as of the applicable year-end compared against the prior year-end; plus

•

for awards granted in prior years that vested during the applicable year, the change in value as of the vesting date compared against the prior year-end; plus

•

for any awards granted in the applicable year that vested during the applicable year, the value as of the vesting date; plus

•

the value of any dividend equivalents that were paid during the applicable year that are not otherwise included in total compensation; minus

•

for awards granted in prior years that were forfeited during the applicable year, the value as of the prior year-end.

The specific calculations with respect to the CAP fair value of equity for the relevant years are shown in the tables below:


First PEO – CAP Equity Adjustments	2025				2024			2023

YE Value of Current Year Awards Outstanding as of YE		$	1,104,601			$	2,057,295		$	616,999


Change in Value as of YE for Prior Year Awards Outstanding as of YE		$	—			$	240,247		$	(187,294	)


Change in Value as of Vesting Date for Prior Year Awards That Vested During the Year		$	(195,398	)		$	5,571		$	(21,797	)


Value as of Vesting Date for Current Year Awards That Vested During the Year		$	—			$	—		$	—


Value as of Vesting Date for Dividend Equivalents Paid During the Year Not Otherwise Included in Total Compensation		$	—			$	—		$	—


Value as of Prior YE for Prior Year Awards Forfeited During the Year		$	—			$	—		$	—


Value of Equity for CAP Purposes		$	909,203			$	2,303,113		$	407,908


Second PEO – CAP Equity Adjustments	2025				2022				2021

YE Value of Current Year Awards Outstanding as of YE		$	19,232,391			$	—			$	4,664,583


Change in Value as of YE for Prior Year Awards Outstanding as of YE		$	—			$	—			$	—


Change in Value as of Vesting Date for Prior Year Awards That Vested During the Year		$	(24,236	)		$	(1,748,149	)		$	1,002,070


Value as of Vesting Date for Current Year Awards That Vested During the Year		$	—			$	1,133,119			$	—


Value as of Vesting Date for Dividend Equivalents Paid During the Year Not Otherwise Included in Total Compensation		$	—			$	—			$	—


Value as of Prior YE for Prior Year Awards Forfeited During the Year		$	—			$	—			$	—


Value of Equity for CAP Purposes		$	19,208,155			$	(615,030	)		$	5,666,653


Non-PEO NEOs – CAP Equity Adjustments	2025				2024			2023				2022				2021

YE Value of Current Year Awards Outstanding as of YE		$	4,057,776			$	834,923		$	560,818			$	350,057			$	1,310,553


Change in Value as of YE for Prior Year Awards Outstanding as of YE		$	453,943			$	122,479		$	(150,476	)		$	(496,890	)		$	60,423


Change in Value as of Vesting Date for Prior Year Awards That Vested During the Year		$	(26,542	)		$	2,366		$	(9,414	)		$	(106,757	)		$	37,056


Value as of Vesting Date for Current Year Awards That Vested During the Year		$	—			$	288,498		$	—			$	—			$	—


Value as of Vesting Date for Dividend Equivalents Paid During the Year Not Otherwise Included in Total Compensation		$	—			$	—		$	—			$	—			$	—


Value as of Prior YE for Prior Year Awards Forfeited During the Year		$	—			$	—		$	—			$	—			$	—


Value of Equity for CAP Purposes		$	4,485,177			$	1,248,266		$	400,928			$	(253,590	)		$	1,408,032

Company Selected Measure Name

Adjusted EBITDA

Named Executive Officers, Footnote

Dr. Swift served as our PEO for the entirety of 2024 and 2023. Mr. Ordan served as our PEO for the entirety of 2021 and 2022. For purposes of the table, Dr. Swift is our First PEO and Mr. Ordan is our Second PEO. 2024, our non-PEO NEOs consisted of Ms. Rossi, Ms. Moore, Mr. Richards, Dr. Pickert and Mr. Wood. In 2023, our non-PEO NEOs consisted of Ms. Moore, Mr. Richards, Dr. Pickert and Mr. Wood. In 2022, our non-PEO NEOs consisted of Mr. Richards and Dominic Andreano, our former Executive Vice President and General Counsel, Ms. Moore and Dr. Swift. During 2021, our non-PEO NEOs consisted of Mr. Richards and Andreano, Mr. John C. Pepia, Ms. Moore and Roger “Mack” Hinson, M.D.

Peer Group Issuers, Footnote

(4)

Adjustment To PEO Compensation, Footnote

(5)


Adjustments to Calculate Compensation “Actually Paid” to First PEO(7)	2025				2024				2023


SCT Total		$	2,775,881			$	3,301,012			$	2,237,839


Minus: Grant Date Fair Value of Awards Granted During the Year(8)		$	(730,720	)		$	(1,180,087	)		$	(1,025,015	)


Plus (Minus): CAP Adjustments Calculated Using SEC Methodology(9)		$	909,203			$	2,303,113			$	407,908


CAP Total		$	2,954,364			$	4,424,038			$	1,620,732


Adjustments to Calculate Compensation “Actually Paid” to Second PEO(7)	2025				2022				2021

SCT Total		$	14,140,217			$	4,655,746			$	6,848,969


Minus: Grant Date Fair Value of Awards Granted During the Year(8)		$	(8,456,024	)		$	(3,500,013	)		$	(3,500,021	)


Plus (Minus): CAP Adjustments Calculated Using SEC Methodology(9)		$	19,208,155			$	(615,030	)		$	5,666,653


CAP Total		$	24,892,348			$	540,703			$	9,015,601

Non-PEO NEO Average Total Compensation Amount

$ 3,402,819

$ 2,078,530

$ 1,721,885

$ 1,699,411

$ 2,107,197

Non-PEO NEO Average Compensation Actually Paid Amount

$ 6,034,845

2,611,401

1,191,132

364,560

2,525,213

Adjustment to Non-PEO NEO Compensation Footnote

(5)


Adjustments to Calculate Compensation “Actually Paid” to	2025				2024				2023				2022				2021
Non-PEO NEOs(6)

SCT Total		$	3,402,819			$	2,078,530			$	1,721,885			$	1,699,411			$	2,107,197


Minus: Grant Date Fair Value of Awards Granted During the Year(7)		$	(1,853,151	)		$	(715,395	)		$	(931,681	)		$	(1,081,261	)		$	(990,016	)


Plus (Minus): CAP Adjustments Calculated Using SEC Methodology(8)		$	4,485,177			$	1,248,266			$	400,928			$	(253,590	)		$	1,408,032


CAP Total		$	6,034,845			$	2,611,401			$	1,191,132			$	364,560			$	2,525,213

Equity Valuation Assumption Difference, Footnote

(8)

•

for awards granted during the applicable year (and which are still outstanding), the year-end value; plus

•

for awards granted during prior years that were still outstanding as of the applicable year-end, the change in value as of the applicable year-end compared against the prior year-end; plus

•

for awards granted in prior years that vested during the applicable year, the change in value as of the vesting date compared against the prior year-end; plus

•

for any awards granted in the applicable year that vested during the applicable year, the value as of the vesting date; plus

•

the value of any dividend equivalents that were paid during the applicable year that are not otherwise included in total compensation; minus

•

for awards granted in prior years that were forfeited during the applicable year, the value as of the prior year-end.

The specific calculations with respect to the CAP fair value of equity for the relevant years are shown in the tables below:


First PEO – CAP Equity Adjustments	2025				2024			2023

YE Value of Current Year Awards Outstanding as of YE		$	1,104,601			$	2,057,295		$	616,999


Change in Value as of YE for Prior Year Awards Outstanding as of YE		$	—			$	240,247		$	(187,294	)


Change in Value as of Vesting Date for Prior Year Awards That Vested During the Year		$	(195,398	)		$	5,571		$	(21,797	)


Value as of Vesting Date for Current Year Awards That Vested During the Year		$	—			$	—		$	—


Value as of Vesting Date for Dividend Equivalents Paid During the Year Not Otherwise Included in Total Compensation		$	—			$	—		$	—


Value as of Prior YE for Prior Year Awards Forfeited During the Year		$	—			$	—		$	—


Value of Equity for CAP Purposes		$	909,203			$	2,303,113		$	407,908


Second PEO – CAP Equity Adjustments	2025				2022				2021

YE Value of Current Year Awards Outstanding as of YE		$	19,232,391			$	—			$	4,664,583


Change in Value as of YE for Prior Year Awards Outstanding as of YE		$	—			$	—			$	—


Change in Value as of Vesting Date for Prior Year Awards That Vested During the Year		$	(24,236	)		$	(1,748,149	)		$	1,002,070


Value as of Vesting Date for Current Year Awards That Vested During the Year		$	—			$	1,133,119			$	—


Value as of Vesting Date for Dividend Equivalents Paid During the Year Not Otherwise Included in Total Compensation		$	—			$	—			$	—


Value as of Prior YE for Prior Year Awards Forfeited During the Year		$	—			$	—			$	—


Value of Equity for CAP Purposes		$	19,208,155			$	(615,030	)		$	5,666,653


Non-PEO NEOs – CAP Equity Adjustments	2025				2024			2023				2022				2021

YE Value of Current Year Awards Outstanding as of YE		$	4,057,776			$	834,923		$	560,818			$	350,057			$	1,310,553


Change in Value as of YE for Prior Year Awards Outstanding as of YE		$	453,943			$	122,479		$	(150,476	)		$	(496,890	)		$	60,423


Change in Value as of Vesting Date for Prior Year Awards That Vested During the Year		$	(26,542	)		$	2,366		$	(9,414	)		$	(106,757	)		$	37,056


Value as of Vesting Date for Current Year Awards That Vested During the Year		$	—			$	288,498		$	—			$	—			$	—


Value as of Vesting Date for Dividend Equivalents Paid During the Year Not Otherwise Included in Total Compensation		$	—			$	—		$	—			$	—			$	—


Value as of Prior YE for Prior Year Awards Forfeited During the Year		$	—			$	—		$	—			$	—			$	—


Value of Equity for CAP Purposes		$	4,485,177			$	1,248,266		$	400,928			$	(253,590	)		$	1,408,032

Compensation Actually Paid vs. Total Shareholder Return

The following chart shows the relationship of the compensation actually paid to our PEOs and the average compensation actually paid to our other non-PEO NEOs to the total shareholder return for the Company (“PDX”) and for the S&P 600 Healthcare Index (“S&P 600 HC”).

Compensation Actually Paid vs. Company Selected Measure

The following chart shows the relationship of the compensation actually paid to our PEOs and the average compensation actually paid to our other non-PEO NEOs as compared to our net (loss) income and our Adjusted EBITDA (“AEBITDA”).

Tabular List, Table

Tabular List of Most Important Financial Performance Measures

We consider the below financial performance measures to be the most important measures used by us to link NEO compensation to Company performance. For further information regarding these performance metrics and their function in our executive compensation program, please see “Compensation Discussion and Analysis.”